Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.
about
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsSingle-Cell and Single-Cycle Analysis of HIV-1 ReplicationActivities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophagesAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsNovel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophagesAntiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated stateProgression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells.Host hindrance to HIV-1 replication in monocytes and macrophages.Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageA functional role for ADAM10 in human immunodeficiency virus type-1 replicationAPOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.Robust growth of human immunodeficiency virus type 1 (HIV-1)Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophagesThe inside out of lentiviral vectorsSuccessful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapyDifferential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression.Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcriptionHIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.Epigenetic modulations in activated cells early after HIV-1 infection and their possible functional consequences.Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesisThe Frequency of Cytidine Editing of Viral DNA Is Differentially Influenced by Vpx and Nucleosides during HIV-1 or SIVMAC Infection of Dendritic Cells.Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis.Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcriptionvif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells.55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophagesHypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations.Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages.Vpx is critical for SIVmne infection of pigtail macaques.
P2860
Q24624362-BE9DA98E-51D7-425E-83C5-68A5CB532BE0Q24651506-8A20402F-2BBD-41C2-A8C1-F01A3788DE2EQ27319151-A94E7AA7-3AAB-4DFF-BF49-275B04E0C68AQ28343822-2F35445F-F1BC-4D39-9B8E-EAA8EA81B92EQ28378840-50FC22AA-B1C8-4005-857D-DA6571C9972FQ30445480-80FFDC6E-E611-44B7-8679-BC5020AC79B7Q30968332-6D6AB297-FB1F-4C68-A598-B3602CE24F7AQ33400321-E143ABC5-E87B-45BD-B938-451A8B2AE5B3Q33606917-4B4BA5E7-7A6E-4828-8589-DE8A23206A15Q33783211-7665B1F8-51FD-492A-8360-30836C6137F0Q33846376-F36AA389-F4C3-4135-8EF7-7500B8AE40F8Q33847458-92E8221A-1B7F-4CF4-BFFC-1D7D5528B179Q33864438-6058992D-2C2C-4BD6-9192-6312F1AACD88Q33898509-6DFC7DBD-5D74-473E-ACE1-1760AFCF4A3BQ34037651-CFA89998-9FDB-4F76-8FCA-13D4614CAFD5Q34085094-E77410D2-456D-4BA1-B7C4-27C3B867C556Q34229670-0BE33E80-5CBA-445E-8A66-7FFBD952B273Q34351276-BE4AA87C-4F52-4C20-98FC-9F6FFBF3BDA9Q34386057-7ADF1C79-0D97-46EF-A05B-4D491949712FQ34633466-845000F5-1F96-471E-9451-E4CD9D676CEBQ34761139-87148596-07D1-49FD-A89F-D21C3972A743Q34984509-8054BC3C-3A38-4AE3-A6A2-B140F8C32A36Q35105210-ED419C78-5C9E-4D87-BD4F-60B4F62805BEQ35122784-562BFAE4-77E5-496F-8CB8-326CA3A7B9CEQ35557244-D1BE68DF-F395-41C9-8A03-6FFEF59A85FAQ35601948-30ACC471-7039-47D3-8FE0-EEA56F671051Q35785154-85B83158-3A2B-49C5-AED1-913271D5CF62Q35787684-791498F3-AC77-4EE2-B511-2D896E00AD44Q35819276-139A26FF-9251-4A66-A42D-D790DB4A36F5Q35838727-DD669080-29CD-4BF7-80C7-44E4607E5FC8Q35857366-8EEAC2C2-EDD9-4D60-95E9-A25C2BAD30C1Q35859899-85A03490-147C-4362-86A5-C7D049EC4771Q35862080-9794A8EB-837D-4972-9BC4-757910421F20Q35866177-9D35E878-10BC-402E-9894-2CE917885357Q35871524-C874564E-BDE8-4019-9192-D11FD770BDCDQ35877342-336C6EC4-F5FF-489B-A96D-447F7067A4AFQ35884505-A01D2E17-D206-434C-970F-C317B464431FQ35938679-70C8826F-905C-4A12-BB76-5EF559C3EE7BQ35939279-3C7E9523-A537-4887-AC72-EE4EDC9F6255Q35965316-7D089C3E-CBCA-408F-ACB7-735F64F7624D
P2860
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Kinetics of human immunodefici ...... ions of nucleotide precursors.
@en
type
label
Kinetics of human immunodefici ...... ions of nucleotide precursors.
@en
prefLabel
Kinetics of human immunodefici ...... ions of nucleotide precursors.
@en
P2093
P2860
P1433
P1476
Kinetics of human immunodefici ...... ions of nucleotide precursors.
@en
P2093
P2860
P304
P407
P577
1994-02-01T00:00:00Z